Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Mol Cancer Res. 2014 Sep 24;13(2):231–238. doi: 10.1158/1541-7786.MCR-14-0481-T

Figure 4. Loss of senescencein ARF-null miceis associated with more rapid tumor induction.

Figure 4

A. Kaplan-Meier survival curve comparing mammary tumor-free survival between wildtype and ARF-null mice (n=30, 28) injected with RCAS retrovirus carrying caErbB2.

B. Tumor growth curves of the above mice (n=17, 27).